94 related articles for article (PubMed ID: 7334719)
21. [Comparison of the effectiveness of Cyclophosphamide and Cytembena in controlled clinical trial in nephrotic syndrome and chronic glomerulonephritis].
Sasinka M; Plenta I; Kaiserová E; Izakovic V; Pavlovic M; CYTEMBENA/*THER USE ; Slugen I; Lehký M; Stubna J
Cesk Pediatr; 1976 Mar; 31(3):127-30. PubMed ID: 773556
[No Abstract] [Full Text] [Related]
22. [Dipyridamole therapy in the nephrotic syndrome (author's transl)].
Tojo S; Narita M; Suzuki H; Sano M; Koyama A; Tsuchiya T; Yamamoto S; Tsuchida H; Shishido H; Watanabe K
Nihon Jinzo Gakkai Shi; 1978 Mar; 20(3):255-66. PubMed ID: 671851
[No Abstract] [Full Text] [Related]
23. More about the monitoring indexes of cyclophosphamide therapy in the nephrotic syndrome.
Cecchin E; De Marchi S; Zanello F; Bartoli E
Nephrol Dial Transplant; 1995 Oct; 10(10):1941-2. PubMed ID: 8592612
[No Abstract] [Full Text] [Related]
24. Cyclophosphamide in the treatment of adult nephrotic syndrome.
Gulati PD; Rizvi SN; Ajmani SK; Bhasin RC; Vaishnava H
J Assoc Physicians India; 1973 Jan; 21(1):23-9. PubMed ID: 4792697
[No Abstract] [Full Text] [Related]
25. [Primary corticosteroid-resistant nephrotic syndrome in pediatrics].
Tuya CO; Muñoz M; Costa JA; Repetto HA
Medicina (B Aires); 1984; 44(1):1-7. PubMed ID: 6535901
[No Abstract] [Full Text] [Related]
26. Idiopathic nephrotic syndrome: the frequent relapser.
Phadke M; Bhave S
Indian Pediatr; 1990 Oct; 27(10):1035-8. PubMed ID: 2090589
[No Abstract] [Full Text] [Related]
27. Observations on the "minimal change" lesion: adult onset patients and results of cyclophosphamide treatment in children.
Cameron JS; Ogg CS; White RH
Perspect Nephrol Hypertens; 1973; 1 Pt 1():211-6. PubMed ID: 4536423
[No Abstract] [Full Text] [Related]
28. Ultrastructural changes in minimal lesion nephrotic syndrome before and during cyclophosphamide therapy.
Rathi AK; Bajpai VK; Shipstome AC; Malik GK; Gupta V
Indian Pediatr; 1979 Oct; 16(10):887-95. PubMed ID: 536000
[No Abstract] [Full Text] [Related]
29. Immunosuppression in the nephrotic syndrome.
Lancet; 1976 Nov; 2(7995):1121-2. PubMed ID: 62953
[No Abstract] [Full Text] [Related]
30. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
Podracká L; Böör A; Sasinka M
Cas Lek Cesk; 2008; 147(1):38-43. PubMed ID: 18323041
[TBL] [Abstract][Full Text] [Related]
31. Cyclophosphamide in the treatment of glomerulonephritis.
Ibels LS; Palmer AA; Mahony JF; Stewart JH
Prog Biochem Pharmacol; 1974; 9():65-81. PubMed ID: 4438383
[No Abstract] [Full Text] [Related]
32. Stability of remission in minimal lesion nephrotic syndrome after treatment with prednisolone and cyclophosphamide.
Dundon S; O'Callaghan U; Raftery J
Int J Pediatr Nephrol; 1980 Mar; 1(1):22-5. PubMed ID: 7343524
[No Abstract] [Full Text] [Related]
33. [Effects of corticosteroid and indomethacin treatment on proteinuria].
Michielsen P; Lambert PP
Bull Mem Soc Med Hop Paris; 1967 Feb; 118(3):217-32. PubMed ID: 6058837
[No Abstract] [Full Text] [Related]
34. [Clinical effects of dipyridamole (Persantin) on nephrotic syndrome--multiclinic double blind test (author's transl)].
Ueda Y; Tojo S; Hatano M; Furukawa T; Yoshinaga K; Kinoshita Y; Takeuchi J; Kato E; Ohno J; Kobayashi K; Abe H; Omae S
Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1171-83. PubMed ID: 396401
[No Abstract] [Full Text] [Related]
35. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
Ponticelli C; Edefonti A; Ghio L; Rizzoni G; Rinaldi S; Gusmano R; Lama G; Zacchello G; Confalonieri R; Altieri P
Nephrol Dial Transplant; 1993; 8(12):1326-32. PubMed ID: 8159300
[TBL] [Abstract][Full Text] [Related]
36. [The effect of albumin and furosemide administration in children with primary nephrotic syndrome (author's transl)].
Rego Filho Ede A; Casoni W
Rev Bras Pesqui Med Biol; 1977; 10(5):299-304. PubMed ID: 594431
[TBL] [Abstract][Full Text] [Related]
37. Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis.
Al-Khader AA; Lien JW; Aber GM
Clin Nephrol; 1979 Jan; 11(1):26-30. PubMed ID: 428152
[TBL] [Abstract][Full Text] [Related]
38. Treatment of the nephrotic syndrome in out-patients.
Pochanugool C; Suvanpha R; Sitprija V
J Med Assoc Thai; 1979 Jul; 62(7):345-9. PubMed ID: 479719
[No Abstract] [Full Text] [Related]
39. Alkylating agents in the treatment of nephrotic syndrome.
West CD
Perspect Nephrol Hypertens; 1973; 1 Pt 1():199-210. PubMed ID: 4620919
[No Abstract] [Full Text] [Related]
40. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY; Wu CY; Tsai IJ; Tsau YK
Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
